Literature DB >> 9626809

Melanoma x macrophage hybrids with enhanced metastatic potential.

M Rachkovsky1, S Sodi, A Chakraborty, Y Avissar, J Bolognia, J M McNiff, J Platt, D Bermudes, J Pawelek.   

Abstract

Studies were conducted on the hypothesis that melanoma metastasis might be initiated through the generation of hybrids comprised of cells of the primary tumor and tumor-infiltrating leukocytes. Fusion hybrids were generated in vitro between weakly metastatic Cloudman S91 mouse melanoma cells and normal mouse or human macrophages. Hybrids were implanted s.c. in the tail and mice were monitored for metastases. Controls included parental S91 cells, autologous S91 x S91 hybrids, and B16F10 melanoma cells. Of 35 hybrids tested, most were more aggressive than the parental melanoma cells, producing metastases sooner and in more mice. A striking characteristic was heterogeneity amongst hybrids, with some lines producing no metastases and others producing metastases in up to 80% of mice. With few exceptions, hybrids with the highest metastatic potential also had the highest basal melanin content whereas those with the lowest metastatic potential were basally amelanotic, as were the parental melanoma cells. A spontaneous in vivo supermelanotic hybrid between an S91 tumor cell and DBA/2J host cell was one of the most metastatic lines. Hybrids with the highest metastatic potential also exhibited markedly higher chemotaxis to fibroblast-conditioned media. Histologically, the metastatic hybrids demonstrated vascular invasion and spread to distant organs similar to that of metastatic melanomas in mice and humans. Thus previous findings of enhanced metastasis in leukocyte x lymphoma hybrids can now be extended to include leukocyte x melanoma hybrids. Whether such hybridization is a natural cause of metastasis in vivo remains to be determined; however the fusion hybrids with genetically-matched parents described herein so closely resembled naturally-occurring metastatic melanoma cells that they could serve as useful new models for studies of this complex and deadly phenomenon.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626809     DOI: 10.1023/a:1006557228604

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  89 in total

1.  The analysis of malignancy by cell fusion: the position in 1988.

Authors:  H Harris
Journal:  Cancer Res       Date:  1988-06-15       Impact factor: 12.701

Review 2.  Current concepts of the biology of human cutaneous malignant melanoma.

Authors:  W H Clark; M J Mastrangelo; A M Ainsworth; D Berd; R E Bellet; E A Bernardino
Journal:  Adv Cancer Res       Date:  1977       Impact factor: 6.242

3.  Macrophages in syngeneic animal tumours.

Authors:  R Evans
Journal:  Transplantation       Date:  1972-10       Impact factor: 4.939

4.  Induction of a tumor with greatly increased metastatic growth potential by injection of cells from a low-metastatic H-2 heterozygous tumor cell line into an H-2 incompatible parental strain.

Authors:  R S Kerbel; R R Twiddy; D M Robertson
Journal:  Int J Cancer       Date:  1978-11-15       Impact factor: 7.396

5.  Genotypic and phenotypic evolution of a murine tumor during its progression in vivo toward metastasis.

Authors:  A E Lagarde; T P Donaghue; J W Dennis; R S Kerbel
Journal:  J Natl Cancer Inst       Date:  1983-07       Impact factor: 13.506

6.  Coordinate extinction of melanocyte-specific gene expression in hybrid cells.

Authors:  T P Powers; R L Davidson
Journal:  Somat Cell Mol Genet       Date:  1996-01

7.  Supermelanotic hybrids derived from mouse melanomas and normal mouse cells.

Authors:  R Halaban; J Nordlund; U Francke; G Moellmann; J M Eisenstadt
Journal:  Somatic Cell Genet       Date:  1980-01

8.  The use of cell fusion to analyse factors involved in tumour cell metastasis.

Authors:  I A Ramshaw; S Carlsen; H C Wang; P Badenoch-Jones
Journal:  Int J Cancer       Date:  1983-10-15       Impact factor: 7.396

9.  Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection.

Authors:  R S Kerbel; C Waghorne; M S Man; B Elliott; M L Breitman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

10.  Suppression of properties associated with malignancy in murine melanoma-melanocyte hybrid cells.

Authors:  W F Wakeling; J Greetham; L M Devlin; D C Bennett
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

View more
  48 in total

Review 1.  CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest.

Authors:  E Sick; A Jeanne; C Schneider; S Dedieu; K Takeda; L Martiny
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

2.  Quantification of cell fusion events human breast cancer cells and breast epithelial cells using a Cre-LoxP-based double fluorescence reporter system.

Authors:  Marieke Mohr; Songül Tosun; Wolfgang H Arnold; Frank Edenhofer; Kurt S Zänker; Thomas Dittmar
Journal:  Cell Mol Life Sci       Date:  2015-04-22       Impact factor: 9.261

Review 3.  Cell fusion as a hidden force in tumor progression.

Authors:  Xin Lu; Yibin Kang
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

4.  Macrophage Infiltration in Tumor Stroma is Related to Tumor Cell Expression of CD163 in Colorectal Cancer.

Authors:  Ivan Shabo; Hans Olsson; Rihab Elkarim; Xiao-Feng Sun; Joar Svanvik
Journal:  Cancer Microenviron       Date:  2014-04-28

5.  Genome remodeling upon mesenchymal tumor cell fusion contributes to tumor progression and metastatic spread.

Authors:  Lydia Lartigue; Candice Merle; Pauline Lagarde; Lucile Delespaul; Tom Lesluyes; Sophie Le Guellec; Gaelle Pérot; Laura Leroy; Jean-Michel Coindre; Frédéric Chibon
Journal:  Oncogene       Date:  2020-04-02       Impact factor: 9.867

6.  Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma.

Authors:  Hiromi Kanno; Hiroshi Nishihara; Lei Wang; Sayaka Yuzawa; Hiroyuki Kobayashi; Masumi Tsuda; Taichi Kimura; Mishie Tanino; Shunsuke Terasaka; Shinya Tanaka
Journal:  Neuro Oncol       Date:  2013-03-28       Impact factor: 12.300

7.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

Review 8.  Perspectives on the mesenchymal origin of metastatic cancer.

Authors:  Leanne C Huysentruyt; Thomas N Seyfried
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

Review 9.  GnT-V, macrophage and cancer metastasis: a common link.

Authors:  A K Chakraborty; J M Pawelek
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 10.  Mechanisms of metastasis.

Authors:  Kent W Hunter; Nigel P S Crawford; Jude Alsarraj
Journal:  Breast Cancer Res       Date:  2008       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.